Plegridy Approval Status beta

  • FDA approved: No
  • Brand name: Plegridy
  • Generic name: peginterferon beta-1a
  • Company: Biogen Idec
  • Treatment for: Multiple Sclerosis

Plegridy (peginterferon beta-1a) is a new, longer acting interferon in development for the treatment of multiple sclerosis.

FDA Approval Status for Plegridy

DateArticle
Jul 19, 2013US and EU Regulatory Authorities Accept Plegridy (peginterferon beta-1a) Marketing Applications for Review
May 21, 2013Biogen Idec Submits Application to FDA for Approval of Plegridy (Peginterferon Beta-1a) in Multiple Sclerosis

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here

Close
Hide
(web2)